Effect of chronic acid inhibition on duodenal bulb gastric metaplasia and Helicobacter pylori.
Dogăn
U B
UB
Tunçer
C
C
Dursun
A
A
Kandilci
U
U
D000328:Adult; D016022:Case-Control Studies; D004381:Duodenal Ulcer / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D004386:Duodenum / Q000187:drug effects / Q000473:pathology; D015738:Famotidine / Q000008:administration & dosage*; D005260:Female; D005753:Gastric Mucosa / Q000187:drug effects / Q000473:pathology; D016481:Helicobacter Infections / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D016480:Helicobacter pylori / Q000302:isolation & purification*; D006635:Histamine H2 Antagonists / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D008679:Metaplasia / Q000188:drug therapy; D008875:Middle Aged; D012016:Reference Values; D012189:Retrospective Studies; D013274:Stomach Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D016896:Treatment Outcome
D006635:Histamine H2 Antagonists; D015738:Famotidine